BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 27936964)

  • 1. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.
    Petric R; Besic H; Besic N
    World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
    Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
    J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm.
    Lee SH; Baek JS; Lee JY; Lim JA; Cho SY; Lee TH; Ku YH; Kim HI; Kim MJ
    Endocr Pathol; 2013 Dec; 24(4):177-83. PubMed ID: 24014040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.
    Hulikal N; Re A; Banoth M; Chowhan AK; Yutla M; Sachan A
    Acta Otorhinolaryngol Ital; 2020 Feb; 40(1):33-37. PubMed ID: 32275647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
    Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
    Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?
    Yazici P; Mihmanli M; Bozkurt E; Ozturk FY; Uludag M
    Hormones (Athens); 2016 Apr; 15(2):256-263. PubMed ID: 27376428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules.
    Lee EK; Chung KW; Min HS; Kim TS; Kim TH; Ryu JS; Jung YS; Kim SK; Lee YJ
    J Korean Med Sci; 2012 Sep; 27(9):1014-8. PubMed ID: 22969246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid.
    Besic N; Sesek M; Peric B; Zgajnar J; Hocevar M
    Med Sci Monit; 2008 Sep; 14(9):CR459-67. PubMed ID: 18758416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of serum anti-thyroglobulin antibody and thyroglobulin in the preoperative differential diagnosis of thyroid follicular neoplasms.
    Chen Z; Lin Y; Lai S; Wang P; Li J; Wang L; Guan H; Kuang J
    Endocrine; 2022 May; 76(2):369-376. PubMed ID: 35112214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative measurement of serum thyroglobulin to predict malignancy in thyroid nodules: a systematic review.
    Trimboli P; Treglia G; Giovanella L
    Horm Metab Res; 2015 Apr; 47(4):247-52. PubMed ID: 25384015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
    J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced serum thyroglobulin response to bovine TSH in malignant hypofunctioning solid thyroid nodules: comparison to benign nodular disease.
    Leite Z; Carneiro P; Halpern A; Medeiros-Neto G
    J Endocrinol Invest; 1987 Jun; 10(3):255-9. PubMed ID: 3624800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine Needle Aspiration Cytology and Thyroglobulin Antibodies in Preoperative Diagnosis of Thyroid Malignancy.
    Hasukic B; Jakubovic-Cickusic A; Sehanovic E; Osmic H
    Med Arch; 2019 Dec; 73(6):382-385. PubMed ID: 32082004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thyroglobulin improves the sensitivity of the McGill Thyroid Nodule Score for well-differentiated thyroid cancer.
    Scheffler P; Forest VI; Leboeuf R; Florea AV; Tamilia M; Sands NB; Hier MP; Mlynarek AM; Payne RJ
    Thyroid; 2014 May; 24(5):852-7. PubMed ID: 24341425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
    Hocevar M; Auersperg M
    Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
    Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
    Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.